Insmed Incorporated (INSM)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 26.38 |
| Open | 26.57 |
| Bid | 25.86 x 100 |
| Ask | 25.99 x 400 |
| Day's Range | 25.31 - 26.82 |
| 52 Week Range | 18.09 - 32.00 |
| Volume | |
| Avg. Volume | 1,809,739 |
| Market Cap | 3.859B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.34 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 44.56 |
Insider MonkeyInsmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript
Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript May 9, 2024 Insmed Incorporated beats earnings expectations. Reported EPS is $-1.05817, expectations were $-1.21. Insmed Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name […]
GuruFocus.comInsmed Inc (INSM) Reports Q1 2024 Earnings: Misses EPS Estimates, Revenue Grows Amidst Clinical ...
A Detailed Look at Insmed's Financial Performance and Strategic Clinical Updates
ZacksInsmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
Insmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.
© 2024 Yahoo. All rights reserved.